公开(公告)号：US12088137B2

公开(公告)日：2024-09-10

申请号：US17334046

申请日：2021-05-28

Applicant: Roche Diabetes Care, Inc. ,  Roche Diabetes Care, Inc.

Inventor： Klaus Conrad ,  Walter Fieber

IPC: G01R31/385 ,  A61M5/142 ,  H02J7/00

CPC classification number: H02J7/007184 ,  A61M5/14244 ,  H02J7/0047 ,  A61M2205/18 ,  A61M2205/8206

Abstract: The present disclosure relates to a method for powering up a medical device powered by a battery. The method includes executing an initial battery test. In the initial battery test, a difference voltage between a battery voltage measured without and with a test load is determined. The test load is favorably dimensioned not to significantly stress the battery. The difference voltage is compared with a difference voltage threshold, the difference voltage threshold being predefined in dependence of the no-test-load voltage. The method further includes providing an alarm if the difference voltage is above the difference voltage threshold. The present disclosure further concerns a medical device that implements the method and a method for determining the relation between the difference voltage and the difference voltage threshold. The disclosure can be used to ensure that an alarm is provided if a newly inserted battery is too weak to power the medical device.

公开(公告)号：US20210288515A1

公开(公告)日：2021-09-16

申请号：US17334046

申请日：2021-05-28

Applicant: Roche Diabetes Care, Inc. ,  Roche Diabetes Care, Inc.

Inventor： Klaus Conrad ,  Walter Fieber

IPC: H02J7/00 ,  A61M5/142

Abstract: The present disclosure relates to a method for powering up a medical device powered by a battery. The method includes executing an initial battery test. In the initial battery test, a difference voltage between a battery voltage measured without and with a test load is determined. The test load is favorably dimensioned not to significantly stress the battery. The difference voltage is compared with a difference voltage threshold, the difference voltage threshold being predefined in dependence of the no-test-load voltage. The method further includes providing an alarm if the difference voltage is above the difference voltage threshold. The present disclosure further concerns a medical device that implements the method and a method for determining the relation between the difference voltage and the difference voltage threshold. The disclosure can be used to ensure that an alarm is provided if a newly inserted battery is too weak to power the medical device.

公开(公告)号：US20250017623A1

公开(公告)日：2025-01-16

申请号：US18899202

申请日：2024-09-27

Applicant: Roche Diabetes Care, Inc.

Inventor： Harald Braun ,  Friedhelm Kreutz ,  Olaf Roscher ,  Roland Hans Wiegand

IPC: A61B17/34 ,  A61B5/145 ,  A61M5/158

Abstract: An insertion system comprising at least one screw coupling configured for coupling at least one first element and at least one second element of the insertion system is disclosed. The screw coupling is configured such that the first element and the second element are assembled without rotational movement. The screw coupling comprises at least one radially flexible part configured for radial movement and/or deformation when assembling the first element and the second element, wherein the radially flexible part is a part of the first element or second element; and elastic means configured for applying a force in an axial direction to the screw coupling, wherein the elastic means is pre-loadable in the axial direction during assembly of the insertion system.

公开(公告)号：US12191024B2

公开(公告)日：2025-01-07

申请号：US17316240

申请日：2021-05-10

Applicant: Roche Diabetes Care, Inc.

Inventor： Mark Gilmore Mears

IPC: G16H20/60 ,  G06V20/20 ,  G16H20/17 ,  G16H40/63 ,  H04W4/029

Abstract: Management of a diabetic condition may be performed by detecting a mealtime and/or an increased level of activity associated with a user. The mealtime is detected based one or more mealtime indicators that may indicate a likelihood of an occurrence of a mealtime. Each mealtime indicator provides additional context around the likelihood of a mealtime. To assist in managing the diabetic condition, a user's elevated activity levels may be detected. The activity level of a user is detected based on one or more activity indicators. Each activity indicator provides additional context around the likelihood of an increased level of activity by the user. Management of the diabetic condition may be performed proximate a mealtime or a user exercising to increase the efficacy of management of the diabetic condition.

公开(公告)号：US20240412609A1

公开(公告)日：2024-12-12

申请号：US18810169

申请日：2024-08-20

Applicant: Roche Diabetes Care, Inc.

Inventor： Harald von Campenhausen

IPC: G08B13/196 ,  H04N7/18 ,  H04N23/661

Abstract: This disclosure lies in the field of a computer implemented method of routing a video call from a call center computer system comprising a controller, a transceiver, and a machine learning system, to a product service agent computer system assigned to a certain medical device product type and associated services. This disclosure involves using artificial intelligence in order to identify a medical device product based on recorded product image data. Further aspects of this disclosure provide a corresponding call center computer system for routing a video call initiated by a mobile device from the call center computer system to a medical device product service agent computer system as well as a computer-implemented method for generating a model of a medical device product type.

公开(公告)号：US20240398499A1

公开(公告)日：2024-12-05

申请号：US18798437

申请日：2024-08-08

Applicant: Roche Diabetes Care, Inc.

Inventor： Matthias Huisinga ,  Liang Yi Li ,  Chun-Wei Liu

IPC: A61B50/30 ,  A61B50/00

Abstract: A body-wearable medical device has first and second housing portions. The first housing portion has a female portion and the second housing portion has a male portion. The male portion is at least partially inserted into the female portion, thereby defining a circumferential clearance gap. A circumferential sealing element is arranged in the circumferential clearance gap between the female portion and the male portion. In order to provide a body-wearable medical device with improved sealing that is less prone to failure by stress and forces exerted on the body-wearable medical device, the female portion and the male portion are fixed to each other by a circumferential fixation glue arranged in the circumferential clearance gap between the female portion and the male portion next to the circumferential sealing element.

公开(公告)号：US12135292B2

公开(公告)日：2024-11-05

申请号：US17142129

申请日：2021-01-05

Applicant: Roche Diabetes Care, Inc.

Inventor： Max Berg ,  Daniel Sieffert ,  Volker Tuerck ,  Simon Wetzel ,  Momme Winkelnkemper

IPC: B01L3/00 ,  B01F23/00 ,  B01F23/41 ,  B01F101/23 ,  B23Q17/24 ,  C07K14/705 ,  C12M1/34 ,  C12Q1/04 ,  C12Q1/18 ,  C12Q1/686 ,  G01N21/3577 ,  G01N21/359 ,  G01N21/39 ,  G01N21/45 ,  G01N21/64 ,  G01N21/77 ,  G01N21/78 ,  G01N27/414 ,  G01N30/12 ,  G01N30/68 ,  G01N30/70 ,  G01N30/72 ,  G01N30/88 ,  G01N33/00 ,  G01N33/18 ,  G01N33/50 ,  G01N33/53 ,  G01N33/543 ,  G01N33/68 ,  G01N33/74 ,  G01N35/00 ,  G01N35/10 ,  G06T7/00 ,  G06T7/90 ,  H10K10/46 ,  H10K85/00 ,  H10K85/20

Abstract: A method for detecting an analyte in a sample is disclosed. The method includes providing a mobile device having a camera and an illumination source. A test strip having a test field with at least one test chemical for performing an optical detection reaction in the presence of the analyte is provided. The sample is applied to the test field. Several images of a region of the test strip are captured. The region includes at least part of the test field to which sample is applied. The images are captured before and after the sample is applied and with the illumination source turned on and off. The images captured are compared and differences in light intensities are determined. Analyte concentration is determined using the images captured and the determined light intensities.

公开(公告)号：US12082928B2

公开(公告)日：2024-09-10

申请号：US18365778

申请日：2023-08-04

Applicant: Roche Diabetes Care, Inc.

Inventor： Ahmet Konya

IPC: A61B5/1486 ,  A61B5/00

CPC classification number: A61B5/14865 ,  A61B5/6832 ,  A61B2560/0214 ,  A61B2560/0456 ,  A61B2560/063 ,  A61B2562/12 ,  A61B2562/242 ,  A61B2562/247

Abstract: An inventive medical system has a housing with a first guiding surface. A preassembled module is received in the housing. The module includes electronics electrically connected to an analytical sensor, an insertion component configured for inserting the analytical sensor into body tissue of a user and a sterility cap at least partially surrounding the insertion component. The module has a second guiding surface. A protective cap is removably connected to the housing and covers the preassembled module. The protective cap is removable from the housing by pulling the protective cap from the housing. The first guiding surface guides the protective cap during the pulling of the protective cap from the housing and the second guiding surface guides the sterility cap during pulling the sterility cap from the insertion component. The length of the first guiding surface exceeds the length of the second guiding surface.

公开(公告)号：USD1039561S1

公开(公告)日：2024-08-20

申请号：US29820917

申请日：2021-12-24

Applicant: Roche Diabetes Care, Inc.

Designer： Gabriele Schoepfer

Abstract: The patent or application file contains at least one drawing executed in color. Copies of this patent or patent application publication with color drawing(s) will be provided by the Office upon request and payment of the necessary fee.
The FIGURE is a front view of a display screen with graphical user interface for glucose management, showing our new design.
The outer broken lines illustrate a portion of a display screen and form no part of the claimed design. The text and numerals shown in broken line in the graphical user interface form no part of the claimed design.

公开(公告)号：US12064245B2

公开(公告)日：2024-08-20

申请号：US18365822

申请日：2023-08-04

Applicant: Roche Diabetes Care, Inc.

Inventor： Ahmet Konya

IPC: A61B5/1486 ,  A61B5/00

CPC classification number: A61B5/14865 ,  A61B5/6832 ,  A61B2560/0214 ,  A61B2560/0456 ,  A61B2560/063 ,  A61B2562/12 ,  A61B2562/242 ,  A61B2562/247

Abstract: An inventive medical system has a housing with a first guiding surface. A preassembled module is received in the housing. The module includes electronics electrically connected to an analytical sensor, an insertion component configured for inserting the analytical sensor into body tissue of a user and a sterility cap at least partially surrounding the insertion component. The module has a second guiding surface. A protective cap is removably connected to the housing and covers the preassembled module. The protective cap is removable from the housing by pulling the protective cap from the housing. The first guiding surface guides the protective cap during the pulling of the protective cap from the housing and the second guiding surface guides the sterility cap during pulling the sterility cap from the insertion component. The length of the first guiding surface exceeds the length of the second guiding surface.